maduramicin has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gao, X; Guo, D; Ji, C; Ji, H; Jiang, S; Peng, L; Qiu, Y; Song, X; Yang, D; Zuo, R | 1 |
Bharti, H; Ghosh, PC; Nag, A; Raza, M; Singal, A | 1 |
Czesny, B; Huang, R; Magle, CT; Maron, MI; Turturice, BA; Vaidya, AB; Williamson, KC; Zheng, W | 1 |
3 other study(ies) available for maduramicin and Disease Models, Animal
Article | Year |
---|---|
Ionophore Toxin Maduramicin Produces Haff Disease-Like Rhabdomyolysis in a Mouse Model.
Topics: Animals; Astacoidea; Creatine Kinase; Disease Models, Animal; Ionophores; Lactones; Mice; Rhabdomyolysis | 2020 |
Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Carriers; Female; HEK293 Cells; Hep G2 Cells; Humans; Lactones; Liposomes; Malaria; Mice; Plasmodium falciparum | 2018 |
Maduramicin Rapidly Eliminates Malaria Parasites and Potentiates the Gametocytocidal Activity of the Pyrazoleamide PA21A050.
Topics: Animals; Antimalarials; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Erythrocytes; Female; Gametogenesis; Lactones; Malaria; Mice, Inbred Strains; Plasmodium berghei; Plasmodium falciparum; Pyrazoles; Schizonts | 2015 |